Navigation Links
Researchers From More Than 30 Countries Share Findings About the Use of Ultrasound in the Prevention, Diagnosis and Treatment of Heart Disease
Date:6/11/2011

MONTREAL, June 11, 2011 /PRNewswire/ -- The world's leading researchers in cardiovascular medicine will present their most-recent findings at the American Society of Echocardiography (ASE) 22nd Annual Scientific Sessions, June 11-14, 2011 in Montreal, Quebec, Canada.  Many of this year's presentations will significantly impact the diagnosis and treatment of heart disease and the utilization of cardiovascular ultrasound.

To view the full text of the press releases, please visit the "ASE Press Room" link on the Society's Website, asecho.org.

One of this year's top studies, presented by scientists from St. Michael's Hospital in Toronto, discovered that echocardiography could improve the success rate of gene therapy and increase growth, function and sustainability of regenerated vessels. The research revealed that echo-guided gene therapy is beneficial for individuals suffering from chronic vascular disease and could potentially translate to improved quality of life for hundreds of thousands of North Americans suffering from peripheral vascular disease and coronary artery disease.

In another study, childhood obesity was identified as an important factor in the progression to heart failure. Researchers found that new non-invasive heart ultrasound techniques will help to identify changes in the heart muscle function that occurs before a child shows signs of cardiac problems.

"There is a great interest in identifying and studying factors that lead to cardiac dysfunction," said Dr. Gautam Singh, a pediatric cardiologist and lead researcher of the study at the Washington University School of Medicine in St. Louis. "Our ability to identify specific health risk factors in adults that are a result of childhood obesity will hopefully sound an alarm to the millions of Americans with children."

Finally, a group of German researchers will show how echocardiography can help predict how the right ventricle will respond to implantation of a mechanical left ventricular support. This study further proves that echo used in pre-operative evaluation gives physicians more information for critical decisions.

Participants from 38 countries are registered to attend this year's event.  The Scientific Sessions will feature prominent speakers from the European Society of Echocardiography, the Japanese Society of Echocardiography as well as faculty from U.S. major medical institutions including: the Cleveland Clinic, Duke University, the Mayo Clinic, the Methodist DeBakey Heart and Vascular Center, Massachusetts General Hospital and the University of Chicago.

About the American Society of Echocardiography

The American Society of Echocardiography (ASE) is a professional organization of physicians, cardiac sonographers, nurses and scientists involved in echocardiography, the use of ultrasound to image the heart and cardiovascular system. The organization was founded in 1975 and is the largest international organization for cardiovascular ultrasound imaging. For more information on ASE, visit www.asecho.org or ASE's public information site, www.SeeMyHeart.org.

CONTACT:
Cathy Kerr
Vice President of Communications
ckerr@asecho.org
919.662-6545


'/>"/>
SOURCE American Society of Echocardiography
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Singapore researchers invent broadband graphene polarizer
2. Livermore researchers develop battery-less chemical detector
3. Researchers create terahertz invisibility cloak
4. UCLA researchers now 1 step closer to controlled engineering of nanocatalysts
5. Researchers pinpoint graphenes varying conductivity levels
6. Pitt-led researchers create super-small transistor, artificial atom powered by single electrons
7. Researchers advance toward hybrid spintronic computer chips
8. Researchers find replacement for rare material indium tin oxide
9. Berkeley Lab researchers report tandem catalysis in nanocrystal interfaces
10. Nanocrystal doping developed by Hebrew University researchers enhances semiconductor nanocrystals
11. TGen and Scottsdale Healthcare researchers discover microRNA role in brain metastasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 08, 2016 , ... Opal Kelly, a leading producer of ... USB or PCI Express, announced the FOMD-ACV-A4, the company's first FPGA-on-Module for integration ... SODIMM-style module that fits a standard 204-pin SODIMM socket for low-cost integrations and ...
(Date:12/8/2016)... England , December 8, 2016 ... has expanded its customisable SureSeq™ NGS panel range with the ... allowing fast and cost-effective study of variants in familial hypercholesterolemia ... number variation (CNV) detection on a single small panel and ... hotspot content. This includes all exons for LDLR , ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... data bioInformatics portal. In response to client demand KbioBox developed a sophisticated “3 ... biodesign program. Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... World Technology Awards. uBiome is one of just six company finalists in the ... In addition to uBiome, companies nominated as finalists in this year’s awards include ...
Breaking Biology Technology:
(Date:11/29/2016)... 29, 2016 Nearly one billion matches per second ... ... DERMALOG is Germany's ... efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification ...
(Date:11/21/2016)... Nov. 21, 2016   Neurotechnology , a ... technologies, today announced that the MegaMatcher On Card ... submitted for the NIST Minutiae Interoperability Exchange ... the mandatory steps of the evaluation protocol. ... continuing test of fingerprint templates used to establish ...
(Date:11/15/2016)... Nov. 15, 2016  Synthetic Biologics, Inc. (NYSE ... focused on the gut microbiome, today announced the ... shares of its common stock and warrants to ... a price to the public of $1.00 per ... Biologics from the offering, excluding the proceeds, if ...
Breaking Biology News(10 mins):